Daxor Corporation Announces $1.35 Per Share NAV Increase and Files Annual Report for Fiscal 2021
March 01, 2022 08:00 ET
|
Daxor Corporation
Revenues of Operating Division Increase by 70.6% Oak Ridge, TN, March 01, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, filed...
Daxor Corporation Commences Trading on The NASDAQ Capital Market
February 02, 2022 08:00 ET
|
Daxor Corporation
Management to Ring the Nasdaq Stock Market Opening Bell on February 4, 2022 Oak Ridge, TN, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume...
Daxor Corporation Announces $0.48 Per Share NAV Increase and Files Annual Report for Fiscal 2020
February 26, 2021 08:30 ET
|
Daxor Corporation
Revenues of Operating Division Increase by 50.4% NEW YORK, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) The global leader in blood volume technology today filed its Annual...
BVA Convention to Feature VA Leadership and International Tech Accessible Industry Leaders in Tulsa, Oklahoma.
July 31, 2019 15:19 ET
|
Blinded Veterans Association
Alexandria, VA, July 31, 2019 (GLOBE NEWSWIRE) -- The Blinded Veteran’s Association’s 74th Annual Convention will be hosted at the Marriot Southern Hills Hotel August 12-16, 2019 in Tulsa, Oklahoma....
New Data Showing Patient Care Individualized by Daxor’s Precision Blood Volume Analysis Reduces Heart Failure Readmissions by 56% and Mortality by over 80% Presented at the American College of Cardiology 2018 Annual Scientific Session
March 14, 2018 08:00 ET
|
Daxor Corporation
(NYSE MKT LLC: DXR) New York, NY, March 14, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with medical instrumentation and biotechnology operations,...